Year archive

Hyloris Pharmaceuticals SA — 2023 filings

All 24 regulatory filings released by Hyloris Pharmaceuticals SA (HYL) in 2023, sourced directly from the official regulator.

24 Filings

2023 Period

2023 filings (24)

Filing	Released	Lang
HY-029 Pivotal Study success-FINAL_en.pdf Legal Proceedings Report	2023-12-26	English
HY-029 Pivotal Study succes_Final_FR.pdf Legal Proceedings Report	2023-12-26	French
20231221 HY-090-EN.pdf Regulatory Filings	2023-12-21	English
20231221 HY-090-FR.pdf Regulatory Filings	2023-12-21	French
Podofilox US Approval EN.pdf Regulatory Filings	2023-12-04	English
Podofilox Approbation FR.pdf Earnings Release FY 2022	2023-12-04	French
231018~1.PDF Regulatory Filings	2023-10-18	English
231018~2.PDF Regulatory Filings	2023-10-18	French
Hyloris Interim Report H1 2023 FINAL-EN.pdf Interim / Quarterly Report H1 2023	2023-09-06	English
Hyloris Interim Report H1 2023 FINAL-FR.pdf Interim / Quarterly Report H1 2023	2023-09-06	French
Hyloris-AGM2023-minutes.pdf AGM Information	2023-06-13	French
Binder1.pdf AGM Information	2023-05-08	French
Hyloris_RA22_v24_25mai_planche.pdf Annual Report FY 2022	2023-04-28	English
Hyloris_RA22_v13_FR_25mai_planche.pdf Annual Report FY 2022	2023-04-28	French
Hyloris_RA22_v24_25mai_planche.pdf Annual Report FY 2022	2023-04-28	English
Hyloris_RA22_v13_FR_25mai_planche.pdf Annual Report FY 2022	2023-04-28	French
875500LZIWS7QEQE0I73-2022-12-31-en.xhtml Annual Report FY 2022	2023-04-28	English
875500LZIWS7QEQE0I73-2022-12-31-en (4).zip Annual Report (ESEF) FY 2022	2023-04-28	English
875500LZIWS7QEQE0I73-2022-12-31-fr (3).zip Annual Report (ESEF) FY 2022	2023-04-28	French
875500LZIWS7QEQE0I73-2022-12-31-fr.xhtml Annual Report FY 2022	2023-04-28	French
PR Annual Results FY22 FINAL.pdf Earnings Release FY 2022	2023-03-15	English
PR Annual Results FY22 FR-FINAL.pdf Earnings Release FY 2022	2023-03-15	French
Hypophosphatemia ENG FINAL.pdf Regulatory Filings	2023-01-20	English
Hypophosphatemia_FR FINAL.pdf Earnings Release Q1 2023	2023-01-20	French